Old Web
English
Sign In
Acemap
>
authorDetail
>
Dale Greenwood
Dale Greenwood
Eli Lilly and Company
QT interval
Bioavailability
Concomitant
Pharmacokinetics
Gastroenterology
3
Papers
3
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Improving Dissolution Behavior and Oral Absorption of Drugs with pH-Dependent Solubility Using pH Modifiers: A Physiologically Realistic Mass Transport Analysis.
2021
Molecular Pharmaceutics
Niloufar Salehi
Gislaine Kuminek
Jozef Al-Gousous
David C. Sperry
Dale Greenwood
Nicholas M. Waltz
Gordon L. Amidon
Robert M. Ziff
Gregory E. Amidon
Show All
Source
Cite
Save
Citations (1)
Evaluation of the effects of an oral notch inhibitor, crenigacestat (LY3039478), on QT interval, and bioavailability studies conducted in healthy subjects
2019
Cancer Chemotherapy and Pharmacology
Eunice Yuen
Maria Posada
Claire Smith
Katharine Thorn
Dale Greenwood
Michelle Burgess
Karim A. Benhadji
Demetrio Ortega
Louise Chinchen
Jeffrey G. Suico
Show All
Source
Cite
Save
Citations (2)
Abstract B082: Evaluation of the effects of an oral Notch inhibitor, LY3039478, on QT interval, and absolute and pilot relative bioavailability studies conducted in healthy subjects
2018
Molecular Cancer Therapeutics
Eunice Yuen
Maria Posada
Claire Smith
Katharine Thorn
Dale Greenwood
Michelle Burgess
Karim A. Benhadji
Demetrio Ortega
Louise Chinchen
Jeffrey G. Suico
Show All
Source
Cite
Save
Citations (0)
1